Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Conditions: B-cell Acute Lymphoblastic Leukemia; Lymphoma; Myeloid Leukemia; Multiple Myeloma; Hepatoma; Gastric Cancer; Pancreatic Cancer; Mesothelioma; Colorectal Cancer; Esophagus Cancer; Lung Cancer; Glioma; Melanoma; Synovial Sarcoma; Ovarian Cancer ; Renal Carcinoma Intervention: Biological: CAR-T cell immunotherapy Sponsors: Shenzhen BinDeBio Ltd.; The First Affiliated Hospital of Zhengzhou University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asbestosis | Brain Tumor | Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Glioma | Hepatocellular Carcinoma | Hospitals | Immunotherapy | Leukemia | Liver Cancer | Lymphoma | Melanoma | Mesothelioma | Myeloma | Sarcomas | Skin Cancer